Published in Obesity and Diabetes Week, May 1st, 2006
According to a study from the United States, "We previously demonstrated the anti-inflammatory effects and renal tissue protection in response to adenosine A2A -receptor (A2A R) activation in acute renal injury. We sought to extend these studies and determine the efficacy of A2A R agonists in a chronic model of renal injury. We hypothesized that A2A agonists mediate renal tissue protection in diabetic nephropathy by reducing glomerular inflammation."
A.S. Awad and colleagues working with the University...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.